espB Resolved · high auto-curated

H37Rv Rv3881c · MTBC0 mtbc0_004115 · 460 aa · 4384789–4386171 MTBC0 (-) · RefSeq NP_218398.1

Genomic neighbourhood (genome browser)

Open in full genome browser →

This gene (outlined) in its genomic context; arrows are neighbouring genes coloured by verdict. Click any gene to navigate. Pan and zoom in the full browser.

Annotation: from legacy to revised

Legacy (H37Rv / Mycobrowser)ESX-1 secretion-associated protein EspB
MTBC0 PGAP re-annotationtype VII secretion system ESX-1 target EspB
Revised (this work)Type VII secretion system ESX-1 target EspB. Pfam: EspB_PE (PF18625.8), EspB_PPE (PF21856.3).
Functional category (TubercuList)cell wall and cell processes

Auto-curated: this verdict and function were generated by rules from PGAP + Pfam + Foldseek and have not been hand-reviewed.

In the literature (TB corpus sweep) 43 publications

43 TB publications mention this gene. 43 publications discuss this gene. Queried separately, 42 records carry a M. tuberculosis context and 7 a non-TB mycobacterial context (species named in the 7-record verified sample: M. smegmatis (4), M. marinum (3)). The three counts come from three distinct PubMed queries (each with its own context filter), so they neither partition the total nor need to add up to it.

5 of 43: the most recently indexed records of the curated sweep at its date, not necessarily the most recent papers on this gene — the exhaustive list below is later and broader and may hold newer ones.
PublicationDate
Control of Mycobacterium tuberculosis protein secretion by ESX-4 and the outer membrane EsxUT-EsxEF complex. doi:10.1038/s41467-025-65061-y 2025
Generation of novel polyclonal antibodies against Mycobacterium tuberculosis lipoarabinomannan, EspB, and Mtb8. doi:10.1007/s00253-025-13588-x 2025
Assembly of the Mycobacterium tuberculosis type VII ESX-1 secretion system in Mycobacterium smegmatis identifies a new transcriptional activator of esx-1 genes and a novel TB vaccine. doi:10.1128/spectrum.01131-25 2025
Phagosomal escape and sabotage: The role of ESX-1 and PDIMs in Mycobacterium tuberculosis pathogenesis. doi:10.1080/08830185.2025.2531828 2025
Proteomic Analysis and Sequential Events During the in-vivo Acquisition of Drug Resistance in Clinical Isolates of Mycobacterium tuberculosis. doi:10.2174/0118715265356091250519032548 2025
43 records returned by the alias sweep

Searched as: Rv3881c, espB, Mb3911c, MMAR_5457 — each in conjunction with a mycobacterial context term. Swept 2026-09-07.

PublicationJournalYear
Control of Mycobacterium tuberculosis protein secretion by ESX-4 and the outer membrane EsxUT-EsxEF complex. doi:10.1038/s41467-025-65061-y Nat Commun 2025
Generation of novel polyclonal antibodies against Mycobacterium tuberculosis lipoarabinomannan, EspB, and Mtb8. doi:10.1007/s00253-025-13588-x names it Appl Microbiol Biotechnol 2025
Assembly of the Mycobacterium tuberculosis type VII ESX-1 secretion system in Mycobacterium smegmatis identifies a new transcriptional activator of esx-1 genes and a novel TB vaccine. doi:10.1128/spectrum.01131-25 Microbiol Spectr 2025
Phagosomal escape and sabotage: The role of ESX-1 and PDIMs in Mycobacterium tuberculosis pathogenesis. doi:10.1080/08830185.2025.2531828 Int Rev Immunol 2025
Proteomic Analysis and Sequential Events During the in-vivo Acquisition of Drug Resistance in Clinical Isolates of Mycobacterium tuberculosis. doi:10.2174/0118715265356091250519032548 Infect Disord Drug Targets 2025
EspB and HtpG interact with the type III-A CRISPR/Cas system of Mycobacterium tuberculosis. doi:10.3389/fmolb.2023.1261613 names it Front Mol Biosci 2023
Evaluation of the Immunogenicity of Recombinant Espb, Espc Proteins from Mycobacterium Tuberculosis and the Fusion Espc/Espb Protein in BALB/C Mice. doi:10.52547/rbmb.11.4.590 names it Rep Biochem Mol Biol 2023
Uptake-independent killing of macrophages by extracellular Mycobacterium tuberculosis aggregates. doi:10.15252/embj.2023113490 EMBO J 2023
Cryo-EM reveals the membrane-binding phenomenon of EspB, a virulence factor of the mycobacterial type VII secretion system. doi:10.1016/j.jbc.2023.104589 names it J Biol Chem 2023
The crystal structure of the EspB-EspK virulence factor-chaperone complex suggests an additional type VII secretion mechanism in Mycobacterium tuberculosis. doi:10.1016/j.jbc.2022.102761 names it J Biol Chem 2023
Novel serological biomarker panel using protein microarray can distinguish active TB from latent TB infection. doi:10.1016/j.micinf.2022.105002 Microbes Infect 2022
Mycobacterium tuberculosis EspK Has Active but Distinct Roles in the Secretion of EsxA and EspB. doi:10.1128/jb.00060-22 names it J Bacteriol 2022
Priming mycobacterial ESX-secreted protein B to form a channel-like structure. doi:10.1016/j.crstbi.2021.06.001 Curr Res Struct Biol 2021
Microarray-based selection of a serum biomarker panel that can discriminate between latent and active pulmonary TB. doi:10.1038/s41598-021-93893-3 Sci Rep 2021
Mycobacterium tuberculosis Binds Human Serum Amyloid A, and the Interaction Modulates the Colonization of Human Macrophages and the Transcriptional Response of the Pathogen. doi:10.3390/cells10051264 Cells 2021
Label-Free Comparative Proteomics of Differentially Expressed Mycobacterium tuberculosis Protein in Rifampicin-Related Drug-Resistant Strains. doi:10.3390/pathogens10050607 Pathogens 2021
High resolution CryoEM structure of the ring-shaped virulence factor EspB from Mycobacterium tuberculosis. doi:10.1016/j.yjsbx.2020.100029 names it J Struct Biol X 2020
Cloning, Expression and Purification of Espc, Espb and Espc/Espb Proteins of Mycobacterium tuberculosis ESX-1 Secretion System. names it Rep Biochem Mol Biol 2020
Polarly Localized EccE(1) Is Required for ESX-1 Function and Stabilization of ESX-1 Membrane Proteins in Mycobacterium tuberculosis. doi:10.1128/JB.00662-19 J Bacteriol 2020
Characterization of G-Quadruplex Motifs in espB, espK, and cyp51 Genes of Mycobacterium tuberculosis as Potential Drug Targets. doi:10.1016/j.omtn.2019.04.022 names it Mol Ther Nucleic Acids 2019
The Role of ESX-1 in Mycobacterium tuberculosis Pathogenesis. doi:10.1128/microbiolspec.TBTB2-0001-2015 Microbiol Spectr 2017
Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis sensitive and resistant Beijing type from a patient with pulmonary tuberculosis. doi:10.1016/j.ijmyco.2016.10.028 Int J Mycobacteriol 2016
Mycobacterium tuberculosis EspB protein suppresses interferon-γ-induced autophagy in murine macrophages. doi:10.1016/j.jmii.2014.11.008 names it J Microbiol Immunol Infect 2016
Serological diagnosis of pulmonary Mycobacterium tuberculosis infection by LIPS using a multiple antigen mixture. doi:10.1186/s12866-015-0545-y BMC Microbiol 2015
Structure of EspB, a secreted substrate of the ESX-1 secretion system of Mycobacterium tuberculosis. doi:10.1016/j.jsb.2015.06.003 names it J Struct Biol 2015
Structure of EspB from the ESX-1 type VII secretion system and insights into its export mechanism. doi:10.1016/j.str.2015.01.002 names it Structure 2015
Pentapeptide boronic acid inhibitors of Mycobacterium tuberculosis MycP1 protease. doi:10.1016/j.bmcl.2014.05.056 Bioorg Med Chem Lett 2014
Novel mycosin protease MycP₁ inhibitors identified by virtual screening and 4D fingerprints. doi:10.1021/ci500025r J Chem Inf Model 2014
The putative propeptide of MycP1 in mycobacterial type VII secretion system does not inhibit protease activity but improves protein stability. doi:10.1007/s13238-013-3089-7 Protein Cell 2013
Understanding specificity of the mycosin proteases in ESX/type VII secretion by structural and functional analysis. doi:10.1016/j.jsb.2013.09.022 J Struct Biol 2013
Mycobacterium tuberculosis EspB binds phospholipids and mediates EsxA-independent virulence. doi:10.1111/mmi.12336 names it Mol Microbiol 2013
Structure of the mycosin-1 protease from the mycobacterial ESX-1 protein type VII secretion system. doi:10.1074/jbc.M113.462036 J Biol Chem 2013
MprAB regulates the espA operon in Mycobacterium tuberculosis and modulates ESX-1 function and host cytokine response. doi:10.1128/JB.01067-12 J Bacteriol 2013
General secretion signal for the mycobacterial type VII secretion pathway. doi:10.1073/pnas.1119453109 Proc Natl Acad Sci U S A 2012
[Stable expression of Mycobacterium tuberculosis protein EspB in RAW264.7]. names it Wei Sheng Wu Xue Bao 2011
High-level expression of Mycobacterium tuberculosis protein EspB in E. coli and preparation of novel anti-EspB monoclonal antibodies. doi:10.1089/hyb.2011.0013 names it Hybridoma (Larchmt) 2011
Mycobacterium tuberculosis MycP1 protease plays a dual role in regulation of ESX-1 secretion and virulence. doi:10.1016/j.chom.2010.02.006 Cell Host Microbe 2010
Serodiagnosis of tuberculous lymphadenitis using a combination of antigens. doi:10.3855/jidc.116 J Infect Dev Ctries 2010
Antigen analysis of Mycobacterium tuberculosis H37Rv culture filtrate proteins. doi:10.1111/j.1365-3083.2007.02064.x Scand J Immunol 2008
A unique Mycobacterium ESX-1 protein co-secretes with CFP-10/ESAT-6 and is necessary for inhibiting phagosome maturation. doi:10.1111/j.1365-2958.2007.05959.x Mol Microbiol 2007
A mycobacterium ESX-1-secreted virulence factor with unique requirements for export. doi:10.1371/journal.ppat.0030105 PLoS Pathog 2007
A mycobacterial virulence gene cluster extending RD1 is required for cytolysis, bacterial spreading and ESAT-6 secretion. doi:10.1111/j.1365-2958.2004.04261.x Mol Microbiol 2004
The regulatory elements of the Mycobacterium tuberculosis gene Rv3881c function efficiently in Escherichia coli. doi:10.1016/S0378-1097(02)01185-0 names it FEMS Microbiol Lett 2003

Title+abstract index only: a paper that names this gene solely in its body text, a figure legend or a supplement is invisible here. That is why this list sits beside the curated layer rather than replacing it - Rv0007's characterisation, found by a full-text sweep, returns zero in this one. Absence from this list is not absence from the literature. Source: PubMed E-utilities sweep (esearch + esummary), every alias of the gene searched in conjunction with a mycobacterial context term; ambiguous common-word aliases excluded. phase198, 2026-09-06.

This layer CITES the literature and adds context; it does not change the verdict or the function stated elsewhere in this fiche. This distinguishes a gene that is dark because nobody has looked from one that is dark despite having been studied. Source: PubMed (whole): H37Rv locus tag + GENE NAME + ortholog identifiers (Mb…, MMAR_…, MSMEG_…, ML…, MAB_…), under a mycobacterial context filter; hits verified against the abstract text. Species-context counts distinguish M. tuberculosis literature from literature on other mycobacteria. phase76/phase77, 2026-07-13.

Intrinsic disorder (sequence + structure) highly disordered

Predicted disorder57% of residues (metapredict) · mean AlphaFold pLDDT 69.8
Disordered regions3 IDR(s), longest 191 aa [0-31, 86-126, 269-460]

carries a substantial disordered region (262/460 residues); disorder is a property, not a function

A property (biophysics), not a function. No LLPS/condensate claim is made from disorder alone. Verdict unchanged. Source: metapredict v3 (Emenecker/Holehouse) per-residue disorder + AlphaFold mean pLDDT (annotation_mtbc P16.13).

Genomic-neighbour overlap (structural caveat) co-directional · 0 % of gene

NeighbourRv3880c (Rv3880c, - strand)
Overlap4 bp, 0 % of this gene's length

co-directional overlap: ordinary (e.g. shared stop/start codons in an operon), not the Rv2438A-type artefact P20.1, derived from GFF3 gene coordinates, 2026-08-03.

Post-translational modifications

1 reported modified residue(s): N-acetylthreonine @2.

Experimentally reported post-translational modification(s). A phosphosite indicates the protein is expressed and is a substrate of the M. tuberculosis Ser/Thr/Tyr kinase signalling network — a regulatory context, NOT a molecular function. Source: UniProt (Modified residue features; PTM sites curated from the M. tuberculosis literature).

CRISPRi vulnerability

Vulnerability index 0.97 (95% CI -1.88 to 5.13). A more negative index = more vulnerable to knockdown (better drug-target quality); indicative threshold VI ≤ -6 = highly vulnerable.

Quantitative CRISPRi knockdown, graded (finer than binary Tn-seq essentiality). Source: CRISPRi vulnerability index (Bosch 2021, supplementary Table S2 'mmc3.xlsx', bulk import via Europe PMC -- supersedes the per-gene pebble.rockefeller.edu scrape of phase46_crispri_vulnerability.py).

Caveat on this estimate. Bosch et al. flag this gene's vulnerability estimate as NOT certain, and here that call has a mechanical cause visible in the library itself: every guide targeting this gene is >=21 nt (str_span=0.221 on a 0-1 scale, near the genome floor), and guide repression strength saturates from 21 nt on -- so the library never sampled a partial knockdown for this gene, only the near-maximal repression plateau. The dose-response fit (and this VI) is therefore essentially unconstrained by data, not merely uncertain -- a limitation of the CRISPRi library design for the non-essential class (Bosch et al. 2021), not a defect in this specific measurement. n_guides=6 is descriptive only and does not predict this. Do not cite this VI as a standalone vulnerability claim.

Legacy record & comparison (Mycobrowser)

Mycobrowser functionFunction unknown. Is a proteolytic substrate of MYCP1|Rv3883c.

The legacy Mycobrowser record is shown for verification. Mycobrowser is no longer maintained; its EC numbers predate recent nomenclature revisions, so a class change usually reflects re-numbering, not a conflict.

Orthologues (reciprocal best hits across mycobacteria)

M. bovis Mb3911c · 97.8% identity
M. marinum MMAR_5457 · 64.7% identity
M. orygis RJtmp_003997 · 100.0% identity

Reciprocal-best-hit orthologues (DIAMOND) against the Mycobrowser reference proteomes. A missing species is informative: e.g. a gene absent from M. leprae was likely lost in its reductive genome evolution. Locus tags link to Mycobrowser.

Curated reference (UniProt)

UniProt P9WJD9 SwissProt · reviewed · Evidence at protein level
UniProt nameESX-1 secretion-associated protein EspB
Curated functionRequired for host-cell death and may support an EsxA-independent virulence function. Secreted processed form of EspB binds to phosphatidic acid and phosphatidylserine. Inhibits IFN-gamma-induced autophagy in murine macrophages.

Functional vocabulary (eggNOG-mapper, orthology transfer)

Preferred nameespB
Orthologous group2F9DC
Gene Ontology (29) GO:0002790, GO:0003674, GO:0005488, GO:0005515, GO:0005575, GO:0005576, GO:0006810, GO:0008104, GO:0008150, GO:0009306, GO:0009405, GO:0009987 +17 more

Orthology-based transfer (eggNOG 5.0.2, diamond). EC/KO/GO/CAZy are computed annotations, not manual curation; cross-check against the primary literature before treating a specific reaction as established.

Conservation & selection (intra-MTBC, 142 601 strains, snapshot of 2026-09-29) pseudogene candidate

pN/pS 1.571 · diversifying/relaxed
Polymorphic sites (≥ 0.1% of strains) 3 synonymous, 14 missense, 0 nonsense, 3 frameshift
Disruption 3 distinct premature-stop/frameshift site(s); most common in 4.54% of strains (6475) · clonal
Which clade carries which site (attribution) héritage d'un ancêtre commun (même site dans plusieurs clades) — Bovis, Caprae_La2, La4; union over all sites: 12 548 strains (the count above is a maximum over sites, not a union).
  • NC_000962.3:4361061:CG:C · frameshift · 6 475 strains — fixed in 126 sub-clades of Bovis, Caprae_La2, La4, totalling 7 404 strains — 54.9% of the 13 490 strains in the lineages named (largest: Bovis.2.2.1.2.2.2.1.1.1.1.2.9 1222/1763, Bovis.2.2.1.2.2.2.1.1.1.1.1.2.2.2.2.1.3 330/480, Bovis.2.2.1.2.2.2.1.1.1.1.3.3 297/346, Bovis.2.2.1.2.2.2.1.2.3.2 244/315, Bovis.2.2.1.2.2.2.1.1.1.1.1.2.2.7 118/212, Bovis.2.2.1.2.2.2.1.1.1.1.1.2.1.7.2 120/191, …)
  • NC_000962.3:4361084:C:CG · frameshift · 5 912 strains — fixed in 110 sub-clades of Bovis, Caprae_La2, La4, totalling 6 445 strains — 47.8% of the 13 490 strains in the lineages named (largest: Bovis.2.2.1.2.2.2.1.1.1.1.2.9 1075/1763, Bovis.2.2.1.2.2.2.1.1.1.1.1.2.2.2.2.1.3 269/480, Bovis.2.2.1.2.2.2.1.1.1.1.3.3 282/346, Bovis.2.2.1.2.2.2.1.2.3.2 225/315, Bovis.2.2.1.2.2.2.1.1.1.1.1.2.1.7.2 120/191, Bovis.2.2.1.2.2.2.1.1.1.1.1.2.2.2.2.2.2.1 126/180, …)
  • NC_000962.3:4361208:GT:G · frameshift · 161 strains — not fixed in any clade
Which clade carries which disrupting site — the question the count above never asked. `disrupt_strains` is a MAXIMUM over sites, not a union: two sites carried by two disjoint clades do not add up there. `disrupt_mode` is derived from the NUMBER of sites alone (convergent at 4 or more), so it says nothing about who carries them. Read this field instead for any evolutionary claim, and mind the distinction it enforces: several clades at the SAME site is shared ancestry, not convergence — convergence requires DIFFERENT sites in DIFFERENT clades. SECOND CORRECTION (P44.8, same day): a clade name listed here is the ROOT of the fine clade that fixes the site, not the whole lineage. Across the 789 fixed sites of this atlas, the fixing sub-clades cover a median of 9.2% of the lineage named, and under 10% for half of them — so read the sub-clade sizes given here, never the lineage name alone.

Read the disruption percentage against its ceiling, not against 100%. The strain collection is deeply imbalanced by clade, so a loss fixed in an entire lineage still shows a small overall fraction: a gene disrupted in every L6 strain caps at 0.96% of the collection, in every M. caprae strain at 0.20%, in every M. microti strain at 0.02%. Of the 705 clades in this collection, 689 have a ceiling below 1%. A figure of "0.15% of strains" is therefore uninterpretable on its own — it can be noise or a complete, lineage-defining loss. Use the clade attribution row above, which gives the sub-clade sizes, and never read the percentage alone.

pN/pS from segregating SNPs (singletons removed) normalised by possible sites. Low pN/pS = purifying selection (a strong signal that a "hypothetical" is a real, constrained gene). A high pN/pS is ambiguous: relaxed constraint or positive selection (drug resistance, antigenic variation) inflate it; e.g. rpoB/katG/pncA score high here for resistance, not loss of function. A clonal disruption (one allele over a clade) suggests lineage pseudogenisation; a convergent one (many independent alleles) is typical of resistance loss-of-function.

Outgroup conservation (beyond the MTBC) Mycobacterium

M. canettii dN/dS (deep-divergence selection) 0.0 (low power) · 2 consensus substitution(s)
low power (2 canettii-consensus substitution(s)); present in M. canettii but dN/dS not reliable
Limitation: dN/dS mixes fixed canettii-H37Rv divergence with intra-canettii polymorphism, and is not polarised (the per-gene repolarisation is not viable: 79 % of the consensus SPDI lie outside the polarised table).
Genus-wide presence (~53 non-MTBC Mycobacterium) present in 30/53 (57%) · mean identity 57.2% · 4/4 closest MTBAP relatives
conserved across the genus (present in 30/53 non-MTBC Mycobacterium genomes, incl. distant relatives) — an ancient core gene predating the genus radiation
Phylostratum (deepest detected homolog) MTBC-specific → Mycobacterium → Mycobacteriaceae → Corynebacteriales → Actinomycetia → Bacteria

present across the genus Mycobacterium (NTM) but not detected in any non-Mycobacterium genome — a Mycobacterium-genus gene

Two orthogonal outgroup signals. M. canettii (the immediate outgroup) gives a deep-divergence dN/dS (a low value confirms a constrained, real gene; shown as confident only at ≥8 substitutions, else flagged low-power). Genus-wide presence/absence (tblastn vs assembled non-MTBC genomes) places the gene on the ancient-core ↔ MTBC-specific axis: a gene absent even from the closest MTBAP relatives is a candidate MTBC-specific innovation (possible host-adaptation factor, to confirm by synteny). The phylostratum extends that axis outside the genus (tblastn vs 13 reference genomes spanning Mycobacteriaceae → Corynebacteriales → Actinomycetia → outside the phylum): it is the deepest clade in which a homolog is still detected, i.e. a proxy for gene age. Read it with the null model in mind: a shallow (young) stratum can also reflect homology-detection failure for short or fast-evolving ORFs, so it is a descriptive axis, not a proof of novelty.

Essentiality (transposon mutagenesis)

DeJesus 2017 callGA · growth-advantage
What the call meansgrowth-advantage: insertions enriched
TA sites (Himar1) 24 in the ORF — 0 in the essential state, 0 growth-defect, 0 non-essential, 24 growth-advantage. Saturation 0.958, mean read count 227.347826087. A region of the protein devoid of TA sites is invisible to this assay: nothing can be inferred about it, in either direction.
All 24 sites lie in this ORF alone (no overlapping CDS shares any), so the call is attributable to this gene.

Genome-wide Himar1 transposon essentiality in H37Rv (DeJesus 2017). An essential call (ES/ESD/GD) is strong, independent evidence that a "hypothetical" locus encodes a functional, selectively required gene — orthogonal to intra-species conservation.

Mutant phenotypes (conditional Tn-seq, MtbTnDB) in-vivo phenotype

Conditionlog2FCqEffect
fitness in mouse infection (in vivo) -1.640.0 required
fitness in mouse infection (in vivo) -1.420.0 required
fitness in mouse infection (in vivo) -1.380.013 required
fitness in mouse infection (in vivo) -1.370.0098 required
fitness in mouse infection (in vivo) -1.230.026 required
fitness in mouse infection (in vivo) -1.180.018 required
fitness in mouse infection (in vivo) -1.180.017 required
fitness in mouse infection (in vivo) -1.170.045 required
fitness in mouse infection (in vivo) -1.170.049 required
fitness in mouse infection (in vivo) -1.160.041 required
fitness in mouse infection (in vivo) -1.140.034 required
fitness in mouse infection (in vivo) -1.120.041 required

Conditional fitness of transposon-disruption mutants across 16 significant condition(s) — the table lists the 12 strongest by |log2FC|, not all 16 (|log2FC|≥1, q≤0.05), from the standardized MtbTnDB compendium. A negative log2FC means the mutant is depleted — the gene contributes to fitness in that condition. An in-vivo defect for a "hypothetical" is strong evidence it matters for infection, even without a known molecular function. Disruption (Tn insertion), not a clean deletion; genetic-interaction screens excluded.

Proteomics (mass spectrometry) detected

MS detectiondetected in 15 of 16 independent MS datasets
Integrated abundance883.0 ppm · rank 256/3519 (92.8th percentile)

Detection by mass spectrometry is direct, experimental evidence that the protein product exists — orthogonal to sequence conservation and to Tn-seq essentiality, and especially decisive for a "hypothetical" locus. Read the dataset count as abundance, not as replication. Measured across this atlas (3,491 detected proteins), the number of datasets a protein appears in tracks its abundance almost monotonically: median 1.2 ppm at 1 dataset of 16, 27 ppm at 10, 392 ppm at 15, 1,325 ppm at 16 — three orders of magnitude. A high count therefore says the protein is abundant more than it says several independent experiments confirmed it. What the count does establish, at any value, is that the product exists.

Predicted localisation (DeepTMHMM + lipobox)

Predictionpredicted membrane protein (1 TM helix)
DeepTMHMM classTM
TM helices (DeepTMHMM)1

Transmembrane topology and signal peptide from DeepTMHMM (deep-learning reference predictor); lipoproteins from a (myco)bacterial lipobox motif. A sequence-based prediction of subcellular context.

Physico-chemical properties (computed, ProtParam)

Length460 aa
Molecular weight47.6 kDa
Theoretical pI4.75
GRAVY-0.483 (hydrophilic)
Aliphatic index67.7
Aromaticity0.043
Instability index45.4 (unstable)

Computed from the ancestral MTBC0 sequence with the ExPASy ProtParam method (Biopython). Descriptive biophysical context: a positive GRAVY flags a hydrophobic (often membrane) protein, a high instability index (>40) predicts a short in-vitro half-life, an extreme pI hints at compartment or binding partner.

Domains (Pfam, hmmscan --cut_ga)

PfamAccessioni-EvalueResiduesDescription
EspB_PEPF18625.8 8.2e-3212–88 ESX-1 secreted protein B PE domain
EspB_PPEPF21856.3 7.8e-66130–281 ESX-1 secretion-associated protein EspB, PPE domain

3D structure (interactive — Mol*/pdbe-molstar)

Experimental structure 4xy3 (PDBe), the strongest available structural evidence for this gene. Drag to rotate, scroll to zoom; hetero-groups (ligands, ions, waters hidden by default) shown as sticks.

Experimental structures (Protein Data Bank) 8 solved

PDBMethodResolutionCoverage
4xy3 X-ray diffraction 3.04 Å 100%
6xzc Electron Microscopy 3.37 Å 100%
3j83 Electron Microscopy 30.0 Å 76%
8ako X-ray diffraction 2.293 Å 65%
7p13 Electron Microscopy 2.29 Å 62%
4xxx X-ray diffraction 1.5 Å 59%
4xwp X-ray diffraction 1.82 Å 59%
4xxn X-ray diffraction 2.14 Å 59%

Experimentally solved structures mapped from the UniProt accession via PDBe/SIFTS (8 total; up to 8 shown, ranked by sequence coverage then resolution). An experimental structure is direct proof of the folded product and the strongest structural evidence — superseding the predicted ESMFold/AlphaFold models below for any covered region.

Genomic context (neighbours & predicted operon) operon of 2

Upstream (5' on genome)espL (- strand, -4 bp gap)
Downstream (3' on genome)eccE1 (- strand, 106 bp gap)
Predicted operon espL · espB

Neighbours from the H37Rv annotation (- strand). The operon is predicted by co-directional intergenic distance (same strand, gaps ≤50 bp) — a transcription-unit hypothesis, not a mapped TSS. For a "hypothetical", co-transcription with a characterised operon is a concrete functional lead (complements the STRING neighborhood channel below).

Published operon evidence (two independent sources)

Roback 2007 (logistic regression: distance + expression correlation, 474 microarrays) operon of 2: espL · espB — agrees with the distance heuristic above
REMap 2016 (RNA-seq coverage continuity, CDC1551, tag MT3996) exponential phase: operon of 4, Rv3879c · Rv3880c · Rv3881c (coverage 170.77)
stationary phase: operon of 4, Rv3879c · Rv3880c · Rv3881c (coverage 245.18) — disagrees with the distance heuristic above

Two independent published operon maps, cited alongside the distance heuristic above: an association corroborating or contradicting the heuristic, never proof of shared function. REMap's RNA-seq coverage continuity is the most direct of the three signals; Roback's logistic regression and the intergenic-distance heuristic are statistical proxies.

Transcriptional regulation (signed TRN: ChIP-seq + TFOE)

Regulated by (1 TF) whiB6 (activates)

Regulatory edges from the ISB signed transcriptional regulatory network (TF ChIP-seq binding, Minch 2015 + TF-overexpression response, Rustad 2014). An edge is regulatory evidence (binding and/or expression change), not necessarily direct. For a "hypothetical", membership in a known regulon (e.g. DosR dormancy, PhoP virulence) is a physiological-context lead, not a function.

Condition: Condition-blind by construction. These edges come from transcription-factor OVEREXPRESSION in a single laboratory condition, so a listed regulator is not a claim that it governs this gene in every circumstance. Measured counter-examples exist within this atlas (see Rv2516c, where the DosR regulon collapses under moxifloxacin while the gene itself rises). Read a regulator as 'capable of shifting this gene', and look for the condition before building a hypothesis on it.

Functional interaction network (STRING v12, guilt-by-association)

Explore full network →

Node colour = verdict, dashed = still uncharacterised; edge colour = evidence (green experimental, orange genomic-context, grey co-expression), width ∝ score. Click a partner to open its page; "Explore full network" to walk the graph.

Closest characterised functional partner: espL (ESX-1 secretion-associated protein EspL), high confidence (score 978, all STRING channels except text-mining; the partner is chosen on its genomic-context evidence).

Showing the 15 strongest of this gene's 38 partners at medium confidence (18 at high confidence). The table is an extract, not a neighbourhood: across the proteome the real median degree is 34 while the served median is 15, so no hub, degree distribution or centrality may be read on this table. Of the 38 partners, 1 rest on an interaction measured in M. tuberculosis itself.

PartnerProductScoreNo text-miningChannels (≥400)
Rv3880c espL ESX-1 secretion-associated protein EspL 995 978 ctx neighborhood:882 coexpression:822 textmining:817
Rv3879c espK measured in Mtb ESX-1 secretion-associated protein EspK 989 912 experimental:900 textmining:886
Rv3882c eccE1 ESX-1 secretion system protein EccE1 923 772 ctx neighborhood:769 textmining:676
Rv3883c mycP1 membrane-anchored mycosin 950 745 ctx neighborhood:731 textmining:812
Rv3864 espE ESX-1 secretion-associated protein EspE 954 737 coexpression:734 textmining:834
Rv3873 PPE68 PPE family protein PPE68 648 531 coexpression:474
Rv1075c exp (transferred) hypothetical protein 496 472 experimental:425
Rv2418c octT exp (transferred) hypothetical protein 495 471 experimental:425
Rv0518 exp (transferred) hypothetical protein 494 470 experimental:425
Rv3866 espG1 ESX-1 secretion-associated protein EspG 711 441 coexpression:441 textmining:505
Rv1975 hypothetical protein 440 440 coexpression:430
Rv0157A dark hypothetical protein 438 439 coexpression:429
Rv0058 dnaB replicative DNA helicase 449 427 coexpression:407
Rv3867 espH ESX-1 secretion-associated protein EspH 713 363 textmining:568
Rv3878 espJ ESX-1 secretion-associated protein EspJ 791 311 textmining:710

STRING combines evidence channels (neighborhood, fusion, cooccurrence, coexpression, experimental, database, text-mining) into a 0–1000 score. The ctx badge marks edges carried by the genomic-context channels (conserved neighborhood, fusion, phylogenetic co-occurrence), which are independent of orthology and structure and the strongest signal for an unknown gene. The no text-mining column recomputes the score from data alone, so a link that does not depend on the literature is visible. Association is a function hypothesis, not proof: corroborate with the operon context and the primary literature before assigning a function.

Where the experimental evidence comes from, and why it matters here. STRING's experimental channel fuses interactions measured in M. tuberculosis with interactions measured in another organism and transferred to this pair by orthology. The two are not equivalent for this atlas, whose standing rule is that better studied elsewhere is not a function established in M. tuberculosis. Measured on the served network: of the 38 229 partner pairs shown across the atlas, 13 483 partner rows carry a non-zero experimental channel, and only 106 pairs rest on an interaction measured in M. tuberculosis itself — 0.3 % of the network. Those 106 are long-established complexes (ESX-1/ESAT-6, RNA polymerase with CarD and RbpA, the Pup–Mpa proteasome, gyrase, Emb, GarA with PknB and PknG, the Rel modules); no still-uncharacterised gene is among them. The reason is not a gap in this atlas but in the literature: there is almost no experimental interactome of this bacterium, IntAct holding 134 curated protein pairs for a ~4 000-gene proteome. A exp (transferred) badge is therefore a lead, never a measurement, and an absence of badge is not evidence that the pair does not interact.

Evidence

  • Legacy H37Rv annotation: ESX-1 secretion-associated protein EspB
  • MTBC0 PGAP product: type VII secretion system ESX-1 target EspB
  • Pfam (hmmscan --cut_ga): EspB_PE PF18625.8 (E=8e-32), EspB_PPE PF21856.3 (E=8e-66)
  • (auto-curated by rules from PGAP + Pfam + Foldseek; not hand-reviewed)

Sources

  • Ancestral sequence & coordinates: Harrison LB et al. (2024), An imputed ancestral reference genome for the MTBC, doi:10.1101/2023.09.07.556366
  • Product annotation: NCBI PGAP on MTBC0; legacy from H37Rv NC_000962.3 (RefSeq NP_218398.1)
  • Domains: Pfam-A via hmmscan --cut_ga — EspB_PE (PF18625.8), EspB_PPE (PF21856.3)
  • Sequence-level signal: ESM Atlas (EvolutionaryScale × BioHub) — exploratory
  • Controlled vocabulary: eggNOG-mapper 2.1.12 (Cantalapiedra et al. 2021, doi:10.1093/molbev/msab293), eggNOG 5.0 DB (Huerta-Cepas et al. 2019) — OG 2F9DC
  • Curated reference: UniProt P9WJD9 (SwissProt, reviewed; Evidence at protein level)
  • Intra-MTBC selection: pN/pS and disruption from SPDI variants of 142 601 MTBC strains (this work, local collection vs H37Rv NC_000962.3)
  • Interaction network: STRING v12.0 (Szklarczyk et al. 2023, doi:10.1093/nar/gkac1000), taxon 83332, CC-BY 4.0 — 38 functional partner(s); context anchor espL
  • Essentiality: genome-wide transposon mutagenesis in H37Rv — DeJesus et al. 2017 (mBio, doi:10.1128/mBio.02133-16, CC BY)
  • Proteomics: integrated mass-spectrometry abundance from PaxDb 5.0 (Huang et al. 2023, doi:10.1016/j.mcpro.2023.100640), taxon 83332 — weighted average of 16 datasets, incl. Schubert et al. 2013 (doi:10.1016/j.chom.2013.04.008) and Albrethsen et al. 2013 (doi:10.1074/mcp.M112.018846)
  • Functional category: TubercuList scheme (Cole et al. 1998, doi:10.1038/31159), via Mycobrowser (Kapopoulou et al. 2011, doi:10.1016/j.tube.2010.09.006)
  • Orthologues: reciprocal best hits (DIAMOND, Buchfink et al. 2021, doi:10.1038/s41592-021-01101-x) against Mycobrowser release 5 reference proteomes
  • Experimental structures: PDBe/SIFTS UniProt→PDB mapping (Dana et al. 2019, doi:10.1093/nar/gky1114)
  • Genomic context / operon: H37Rv annotation; operon predicted by co-directional intergenic distance (Salgado et al. 2000, doi:10.1073/pnas.030539397)
  • Transcriptional regulation: ISB signed TRN — TF ChIP-seq (Minch et al. 2015, doi:10.1038/ncomms6829) + TF overexpression (Rustad et al. 2014, doi:10.1186/gb-2014-15-11-502)
  • Mutant phenotypes: standardized Tn-seq compendium MtbTnDB (Jinich et al. 2025, doi:10.1111/mmi.15370), aggregating many primary Tn-seq studies across conditions
  • Physico-chemical properties: ExPASy ProtParam method via Biopython (Gasteiger et al. 2005), computed from the MTBC0 sequence
  • Predicted localisation: DeepTMHMM (Hallgren et al. 2022, doi:10.1101/2022.04.08.487609) for transmembrane topology and signal peptide
  • Primary literature: none located yet; annotation rests on the domain/homology sources above.

Ancestral MTBC0 protein sequence

>mtbc0_004115|Rv3881c|espB
MTQSQTVTVDQQEILNRANEVEAPMADPPTDVPITPCELTAAKNAAQQLVLSADNMREYLAAGAKERQRLATSLRNAAKAYGEVDEEAATALDNDGEGTVQAESAGAVGGDSSAELTDTPRVATAGEPNFMDLKEAARKLETGDQGASLAHFADGWNTFNLTLQGDVKRFRGFDNWEGDAATACEASLDQQRQWILHMAKLSAAMAKQAQYVAQLHVWARREHPTYEDIVGLERLYAENPSARDQILPVYAEYQQRSEKVLTEYNNKAALEPVNPPKPPPAIKIDPPPPPQEQGLIPGFLMPPSDGSGVTPGTGMPAAPMVPPTGSPGGGLPADTAAQLTSAGREAAALSGDVAVKAASLGGGGGGGVPSAPLGSAIGGAESVRPAGAGDIAGLGQGRAGGGAALGGGGMGMPMGAAHQGQGGAKSKGSQQEDEALYTEDRAWTEAVIGNRRRQDSKESK